NIH Guide: Weekly Index for July 17, 2020

Funding Opportunities

• PHS 2020-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
  (PA-20-260)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Food and Drug Administration
  National Center for Environmental Health
  National Center for Injury Prevention and Control
  National Institute for Occupational Safety and Health
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
  (PA-20-261)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
• PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
  (PA-20-262)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Food and Drug Administration
  National Center for Environmental Health
  National Center for Injury Prevention and Control
  National Institute for Occupational Safety and Health
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
  (PA-20-265)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)
  (PAR-20-256)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Applications for this limited competition FOA will be accepted on a rolling basis, beginning July 13, 2020.
• Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)
  (PAR-20-266)
  National Center for Complementary and Integrative Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): New : October 02, 2020; June 02, 2021; October 04, 2021; June 02, 2022; October 03, 2022; June 02, 2023 Resubmissions: October 19, 2020; June 17, 2021; October 19, 2021; June 17, 2022; October 19, 2022; June 19, 2023
• NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
  (PAR-20-267)
  National Institute on Drug Abuse
  Application Receipt Date(s): September 25, 2020, September 27, 2021, September 26, 2022 The first standard due date for this FOA September 25, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional)
  (PAR-20-269)
  National Institute on Aging
  Application Receipt Date(s): November 10, 2020 No late applications will be accepted for this Funding Opportunity Announcement.
• Limited Competition: International Agency for Research on Cancer (IARC) Monographs Program (R01 Clinical Trial Not Allowed)
  (RFA-CA-20-045)
  National Cancer Institute
  Application Receipt Date(s): December 16, 2020 No late applications will be accepted for this Funding Opportunity Announcement.
• BRAIN Initiative: Tools for Germline Gene Editing in Marmosets (U01 - Clinical Trial Not Allowed)
  (RFA-DA-21-006)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): October 15, 2020 and October 14, 2021
• Using Human Cell Animal Chimera Brains to Study HIV Latency and Pathology R01 - Clinical Trials Not Allowed
  (RFA-DA-21-026)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 13, 2020
• NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional)
  (RFA-NS-21-001)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 28, 2020, September 28, 2021, September 28, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NINDS Morris K. Udall Parkinson's Disease Research Center Without Walls (P20 Clinical Trial Optional)
  (RFA-NS-21-002)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 28, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.